Purple Biotech logo

Purple Biotech Share Price Today

(NASDAQ: PPBT)

Purple Biotech share price is $2.89 & ₹251.34 as on 6 Mar 2025, 2.30 'hrs' IST

$2.89

0.12

(4.15%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Purple Biotech share price in Dollar and Rupees. Guide to invest in Purple Biotech stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Purple Biotech, along with analyst recommendations, forecasts, and comprehensive financials.

Purple Biotech share price movements

  • Today's Low: $2.70
    Today's High: $3.00

    Day's Volatility :9.92%

  • 52 Weeks Low: $2.00
    52 Weeks High: $20.60

    52 Weeks Volatility :90.29%

Purple Biotech (PPBT) Returns

PeriodPurple Biotech LtdIndex (Russel 2000)
3 Months
-30.63%
0.0%
6 Months
-68.0%
0.0%
1 Year
-82.98%
0.0%
3 Years
-95.01%
-11.6%

Purple Biotech (PPBT) Key Statistics

in dollars & INR

Previous Close
$2.7749
Open
$2.9
Today's High
$2.9972
Today's Low
$2.7
Market Capitalization
$7.3M
Today's Volume
$12.5K
52 Week High
$20.6
52 Week Low
$2.0
Revenue TTM
$0.0
EBITDA
$-16.0M
Earnings Per Share (EPS)
$-8.29
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-34.39%

How to invest in Purple Biotech Stock (PPBT) from India?

It is very easy for Indian residents to invest directly in Purple Biotech from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Purple Biotech stock in both Indian Rupees (INR) and US Dollars (USD). Search for Purple Biotech or PPBT on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Purple Biotech or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Purple Biotech shares which would translate to 0.301 fractional shares of Purple Biotech as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Purple Biotech, in just a few clicks!

Returns in Purple Biotech (PPBT) for Indian investors in Rupees

The Purple Biotech stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Purple Biotech investment value today

Current value as on today

₹22,693

Returns

₹77,307

(-77.31%)

Returns from Purple Biotech Stock

₹82,270 (-82.27%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Purple Biotech (PPBT)

-64%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Purple Biotech Stock from India on INDmoney has decreased by -64% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Purple Biotech

  • Kingswood Wealth Advisors LLC

    1.30%

  • TWO SIGMA SECURITIES, LLC

    0.60%

  • UBS Group AG

    0.42%

  • Group One Trading, LP

    0.33%

  • BNP Paribas Arbitrage, SA

    0.21%

  • Morgan Stanley - Brokerage Accounts

    0.20%

Analyst Recommendation on Purple Biotech

Analyst Forecast on Purple Biotech Stock (PPBT)

What analysts predicted

Upside of 1041.87%

Target:

$33.00

Current:

$2.89

Insights on Purple Biotech Stock (Ticker Symbol: PPBT)

  • Price Movement

    In the last 6 months, PPBT stock has moved down by -68.0%
  • PPBT vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.3% return, outperforming this stock by 145.0%
  • PPBT vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 47.7% return, outperforming this stock by 142.9%

Purple Biotech Technicals Summary

Sell

Neutral

Buy

Purple Biotech is currently in a neutral trading position according to technical analysis indicators.

Purple Biotech (PPBT) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Purple Biotech Ltd logo
-12.19%
-68.0%
-82.98%
-95.01%
-96.7%
Regeneron Pharmaceuticals, Inc. logo
1.3%
-41.29%
-30.51%
9.2%
42.38%
Beone Medicines Ltd logo
15.19%
34.31%
61.3%
43.16%
68.1%
Vertex Pharmaceuticals Incorporated logo
3.37%
3.77%
18.06%
106.43%
121.36%
Alnylam Pharmaceuticals, Inc. logo
-11.52%
-3.4%
62.32%
49.04%
120.93%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Purple Biotech Ltd logo
0.08
NA
NA
-0.83
-0.34
-0.25
NA
16.98
Regeneron Pharmaceuticals, Inc. logo
17.85
17.85
1.03
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.33
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Purple Biotech Ltd logo
NA
$7.3M
-96.7%
0.08
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$74.9B
42.38%
17.85
31.07%
Beone Medicines Ltd logo
NA
$28.5B
68.1%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.1B
121.36%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.5B
120.93%
NA
-12.37%

About Purple Biotech

Purple Biotech Ltd., a clinical-stage company, focuses on developing therapies to overcome tumor immune evasion and drug resistance for cancer patients in the United States. Its oncology pipeline includes CM24, a humanized monoclonal antibody that blocks the interactions of carcinoembryonic antigen related cell adhesion molecule 1 as a combination therapy with anti-PD-1 checkpoint inhibitors, which is in Phase 2 clinical trial for the treatment of pancreatic ductal adenocarcinoma; NT219, a small molecule that targets and inhibits insulin receptor substrate 1 and 2, and signal transducer and activator of transcription, which is in Phase 1/2 clinical trials for the treatment recurrent and/or metastatic squamous cell carcinoma of the head and neck cancer or colorectal adenocarcinoma; and IM1240, a multi-valent antibody designed to activate anti-tumoral immune response against 5T4-positive tumors, which is in preclinical stage. The company has collaboration agreement with Bristol Myers Squibb Company to evaluate the combination of CM24 with the PD-1 inhibitor nivolumab in addition to chemotherapy; and research collaboration with the Icahn School of Medicine for CAPTN-3 tri-specific antibody platform. The company was formerly known as Kitov Pharma Ltd and changed its name to Purple Biotech Ltd. in December 2020. The company was incorporated in 1968 and is headquartered in Rehovot, Israel.
Organization
Purple Biotech
Employees
20
CEO
Mr. Gil Efron CPA, M.A.
Industry
Miscellaneous

Management People of Purple Biotech

NameTitle
Mr. Gil Efron CPA, M.A.
Chief Executive Officer
Dr. Michael Schickler Ph.D.
Head of Clinical & Regulatory Affairs
Mr. Ido Morpurgo B.Sc., L.L.M.
Vice President of Operations

Important FAQs about investing in PPBT Stock from India :

What is Purple Biotech share price today?

Purple Biotech share price today stands at $2.89, Open: $2.90 ; Previous Close: $2.77 ; High: $3.00 ; Low: $2.70 ; 52 Week High: $20.60 ; 52 Week Low: $2.00.

The stock opens at $2.90, after a previous close of $2.77. The stock reached a daily high of $3.00 and a low of $2.70, with a 52-week high of $20.60 and a 52-week low of $2.00.

Can Indians buy Purple Biotech shares?

Yes, Indians can invest in the Purple Biotech (PPBT) from India.

With INDmoney, you can buy Purple Biotech at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Purple Biotech at zero transaction cost.

How can I buy Purple Biotech shares from India?

It is very easy to buy Purple Biotech from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Purple Biotech (PPBT) be purchased?

Yes, you can buy fractional shares of Purple Biotech with INDmoney app.

What are the documents required to start investing in Purple Biotech stocks?

To start investing in Purple Biotech, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Purple Biotech Stock (PPBT)?

Today’s highest price of Purple Biotech (PPBT) is $3.00.

Today’s lowest price of Purple Biotech (PPBT) is $2.70.

What is today's market capitalisation of Purple Biotech?

Today's market capitalisation of Purple Biotech PPBT is 7.3M

What is the 52 Week High and Low Range of Purple Biotech Stock (PPBT)?

  • 52 Week High

    $20.60

  • 52 Week Low

    $2.00

What are the historical returns of Purple Biotech (PPBT)?

  • 1 Month Returns

    -12.19%

  • 3 Months Returns

    -68%

  • 1 Year Returns

    -82.98%

  • 5 Years Returns

    -96.7%

Who is the Chief Executive Officer (CEO) of Purple Biotech ?

Mr. Gil Efron CPA, M.A. is the current Chief Executive Officer (CEO) of Purple Biotech.